Granulocyte colony-stimulating factor and neutrophil recovery after high-dose chemotherapy and autologous bone marrow transplantation.

Lancet
W P SheridanR M Fox

Abstract

Granulocyte colony-stimulating factor (G-CSF) was administered by continuous subcutaneous infusion to 15 patients with non-myeloid malignancies treated by high-dose chemotherapy and autologous bone marrow infusion. G-CSF was given at variable dosage based on neutrophil count. Sustained serum levels of G-CSF were achieved. Neutrophil recovery was accelerated in G-CSF treated patients compared with 18 historical controls and exceeded 0.5 x 10(9)/l at a mean of 11 days after marrow infusion compared with 20 days for controls, a significant difference. This reduction led to significantly fewer days of parenteral antibiotic therapy, 11 versus 18 days in controls, and less isolation in reverse-barrier nursing, 10 versus 18 days.

References


❮ Previous
Next ❯

Citations

Jul 1, 1991·International Journal of Cell Cloning·W LangeA Lindemann
May 1, 1994·Stem Cells·T Büchner
Jan 1, 1994·Cancer Chemotherapy and Pharmacology·E A PoplinE M Hersh
Nov 1, 1993·Investigational New Drugs·M Aapro
Nov 1, 1993·Cancer Immunology, Immunotherapy : CII·U N Verma, A Mazumder
Jan 1, 1993·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·M MorelN Duedari
Nov 1, 1991·Research in Microbiology·M DenisE O Gregg
Jan 1, 1994·International Journal of Antimicrobial Agents·J J Rusthoven
Oct 1, 1992·Current Opinion in Immunology·R S Negrin, P L Greenberg
Jan 1, 1994·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M BregniA M Gianni
Jan 1, 1996·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·F Sanchiz, A Milla
Jun 1, 1996·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E SouêtreP F Pénelaud
Apr 6, 2004·Developmental and Comparative Immunology·Daniel R BarredaMiodrag Belosevic
Jul 23, 1998·Prostaglandins & Other Lipid Mediators·G L DeliliersM Marconi
Mar 16, 2001·Biochimica Et Biophysica Acta·K H Antman
Jan 15, 1997·International Journal of Radiation Oncology, Biology, Physics·A A KonskiS R Zeidner
Apr 1, 1996·International Journal of Radiation Oncology, Biology, Physics·C KolotasG Schmitt
Jun 25, 1998·Journal of Pharmaceutical and Biomedical Analysis·J L ReubsaetW J Underberg
May 1, 1997·International Journal of Antimicrobial Agents·J J RusthovenA Hamilton
Feb 6, 1997·Transfusion Science·R S EvelyA K Burnett
Jul 11, 1998·Oral Oncology·W ParulekarR C Jordan
May 25, 2010·Nature Reviews. Cancer·Donald Metcalf
Jun 10, 2000·British Journal of Haematology·Y EbiharaK Tsuji
Jul 9, 1992·The New England Journal of Medicine·G J Lieschke, A W Burgess
Feb 5, 2003·The Journal of Experimental Medicine·Patrizia ScapiniMarco A Cassatella
May 23, 2007·The Journal of Experimental Medicine·Kuen-Jer TsaiChe-Kun James Shen
Sep 12, 2000·Journal of Hematotherapy & Stem Cell Research·J H WonH S Park

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.